Insovef 1 mg/ml Oral Çözelti

▼ This medicinal product is subject to additional monitoring. This triangle enables the quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Reporting allows continuous monitoring of the benefit/risk balance of the medicine. Any suspected adverse reaction should be reported to the Turkish Pharmacovigilance Center (TÜFAM) (www.titck.gov.tr; e-mail: tufam@titck.gov.tr; tel: 0800 314 00 08; fax: 0312 218 35 99) and/or to Vefa İlaç San. ve Tic. A.Ş. (www.vefailac.com.tr; info@vefailac.com.tr; tel: +90 212 438 70 85; fax: +90 212 438 70 87).